30 Participants Needed

Stress Testing Protocol for Coronary Heart Disease

BS
Overseen ByBarbra Streisand Women's Heart Center
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Cedars-Sinai Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain, primarily impacts women. There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually. Recent data from our research group suggests that coronary microvascular disease impairs the way the heart relaxes. This pilot study will attempt to exacerbate this phenotype in an effort to better understand the pathophysiology of the disease. The investigators will recruit 30 volunteers total (10 healthy calibration subjects, 10 women with microvascular disease, and 10 age-match women for the group with microvascular disease). Subjects will undergo a series of "stress" maneuvers in conjunction with advanced cardiac magnetic resonance imaging.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.

What data supports the effectiveness of the treatment Altitude simulation, Handgrip, Leg exercise, Exercise stress test, Cardiac stress test for Coronary Heart Disease?

Exercise stress testing is a well-established method for diagnosing and assessing coronary artery disease, and alternative tests like handgrip exercise have been described, though with limited sensitivity. Additionally, high-intensity, occupation-specific training has shown promise in cardiac rehabilitation, suggesting that tailored exercise regimens can be effective in managing heart conditions.12345

Is exercise stress testing safe for humans?

Exercise stress testing is generally safe for humans, with low rates of complications and mortality. Studies show that with proper safety measures and trained staff, it can be safely used even in very ill patients.678910

How does this treatment differ from other treatments for coronary heart disease?

This treatment is unique because it focuses on stress testing protocols that do not require physical exercise, using alternatives like atrial pacing and dipyridamole imaging, which are particularly useful for patients unable to perform traditional exercise tests.19111213

Research Team

MN

Michael Nelson, PhD

Principal Investigator

Cedars-Sinai Medical Center

Eligibility Criteria

This trial is for men and women over 18 who fully understand and agree to the study's procedures. It excludes pregnant women, those unable to consent, with a history of heart/lung/brain diseases, high blood pressure, diabetes, metal implants or claustrophobia (which affects MRI testing), adherence issues, or animal dander allergies.

Inclusion Criteria

Understanding and willing to sign consent form.
I am 18 years old or older.
Fully understanding and willing to undergo study procedures

Exclusion Criteria

I am currently pregnant.
You are allergic to animal fur or hair.
Your blood pressure is consistently higher than 140/90 mmHg when sitting.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Stress Testing

Participants undergo a series of stress maneuvers in conjunction with advanced cardiac magnetic resonance imaging

1-2 weeks
Multiple visits for stress testing and imaging

Follow-up

Participants are monitored for safety and effectiveness after stress testing

4 weeks

Treatment Details

Interventions

  • Altitude simulation
  • Handgrip
  • Leg exercise
Trial OverviewThe study tests how different 'stress' activities like handgrip exercises, leg exercises, and altitude simulation affect small blood vessels in the heart using advanced cardiac MRI. It aims to better understand coronary microvascular dysfunction in women with chest pain but no large artery blockages.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: calibrationExperimental Treatment3 Interventions
10 healthy individuals who will help to synchronize our imaging and stress testing maneuvers.
Group II: Women w/microvascular diseaseExperimental Treatment3 Interventions
10 women with microvascular disease
Group III: Normal controlsExperimental Treatment3 Interventions
10 age-matched women with no evidence of microvascular disease

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cedars-Sinai Medical Center

Lead Sponsor

Trials
523
Recruited
165,000+

Findings from Research

Atrial pacing and dipyridamole imaging are effective alternatives to traditional exercise stress testing for diagnosing coronary artery disease (CAD) in patients who cannot perform leg exercises, showing comparable results.
While the cold pressor test and isometric handgrip exercise have been explored, they have lower sensitivity for detecting CAD, indicating that more research is needed to validate other emerging testing methods like arm ergometry and beta-adrenergic agonist infusions.
Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing.Stratmann, HG., Kennedy, HL.[2019]
A comprehensive testing plan was developed for a 66-year-old man post-aortic dissection repair to assess his ability to safely return to high-intensity outdoor activities, including lifting, hiking, and scuba diving.
After tailored physiological testing and receiving an exercise prescription, the patient successfully engaged in his desired activities within 6 months without experiencing any adverse symptoms.
Specificity of testing in a cardiac rehabilitation setting resulting in a patient's return to high-intensity outdoor activity following aortic dissection repair.Bartee, S., Shrestha, S., Ramos, B., et al.[2020]
Stress testing is essential for diagnosing and managing coronary artery disease, particularly in assessing prognosis and evaluating therapy responses, but is not needed when angina is clinically evident.
The exercise treadmill test remains the most common method for stress testing, and its accuracy can be enhanced with imaging agents or alternative pharmacologic agents for patients unable to exercise.
Evaluating coronary artery disease noninvasively--which test for whom?Chou, TM., Amidon, TM.[2018]

References

Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing. [2019]
Specificity of testing in a cardiac rehabilitation setting resulting in a patient's return to high-intensity outdoor activity following aortic dissection repair. [2020]
Evaluating coronary artery disease noninvasively--which test for whom? [2018]
High-intensity, occupation-specific training in a series of firefighters during phase II cardiac rehabilitation. [2021]
Exercise stress testing--current status. [2018]
Exercise testing: a prospective study of complication rates. [2019]
Clinical exercise stress testing. Safety and performance guidelines. The Cardiac Society of Australia and New Zealand. [2004]
Non-physician-led exercise stress testing is a safe and effective practice. [2013]
Coronary artery disease--diagnosis of ischaemia: general considerations. [2019]
Low Prevalance of Major Events Adverse to Exercise Stress Echocardiography. [2018]
Pharmacologic manipulation of coronary vascular physiology for the evaluation of coronary artery disease. [2015]
Exercise testing in heart failure. A critical review. [2018]
[Stress echocardiography--an evaluation of current status]. [2016]